AzTrials
AzTrials

Specific Learning DisabilityDYSOMNCT06878690

Sleep Disorders in Specific Learning Disabilities

An observational study of Specific Learning Disability and Sleep, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Specific learning disorders, or SLD, are cognitive and behavioral conditions that emerge during childhood and involve significant difficulties in acquiring and performing specific intellectual, motor, language, and social functions. Read more about this study

Who is it for?
Ages 4 years and older
What is being tested?
Online Questionnaire
How many people
1,146 participants
Where
1 siteFrance
Study dates
16 Apr 2025to 16 Apr 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: 1000 participants, 500 children and 500 adults. All with at least one diagnosed specific learning disability

Who may be able to join

  • Children, adolescents and adults with a specific learning disability (dyslexia, dysorthography, dyscalculia, dysgraphia, dyspraxia, dysphasia).
  • ≥ 4 ans

Who cannot join

  • Participant opposing or whose parents oppose participation of this children in the protocol.
  • Patients under guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospices Civils de Lyon

    Bron, 69500

Other trials in France

About this study

Official title: Characterization of Sleep Disorders in Patients With Specific Learning Disabilities According to Age, Sex, Associated Comorbidities and Treatments

Specific learning disorders, or SLD, are cognitive and behavioral conditions that emerge during childhood and involve significant difficulties in acquiring and performing specific intellectual, motor, language, and social functions. These disorders impact personal, social, academic, and professional functioning throughout life. In France, between 6% and 8% of the population, including both children and adults, are affected by at least one type of SLD.

SLD are also frequently associated with Attention Deficit Hyperactivity Disorder (ADHD), with prevalence rates ranging from 33% to 70%, depending on the study. This comorbidity leads to more severe attention and learning difficulties than when ADHD or SLD occur independently.

Read more

ADHD is a common neurodevelopmental disorder that affects cognitive attentional processes, with or without hyperactivity. It is estimated to affect approximately 5.3% of children and adolescents worldwide and about 3% of adults.

The assessment of these disorders is conducted through a neuropsychological evaluation, which determines the type and severity of cognitive impairments.

Several studies report that 55% to 74% of children with ADHD experience sleep difficulties.

To date, only two studies have examined the prevalence of sleep disorders among children with SLD disorders. One of these studies focused exclusively on dyslexia, with or without ADHD. The results revealed significantly higher scores among dyslexic children compared to controls when completing sleep disorder assessment questionnaires (SDSC). The main difficulties were related to "sleep onset and maintenance disorders," "sleep-related breathing disorders," and "wakefulness disorders." The second study, using the same questionnaire, compared children with ADHD, SLD disorders, and both combined. The group with co-existing SLD and ADHD disorders exhibited significantly more sleep disturbances than the other groups, primarily sleep onset and maintenance disorders.

Despite the importance of these studies, they focused only on sleep disorders associated with dyslexia, without considering other learning disorders such as dyspraxia, dyscalculia, or dysgraphia. Furthermore, when ADHD was taken into account, the studies did not differentiate between its various forms, limiting the interpretation of the results. Additionally, no research has tracked the evolution of sleep disorders in the SLD +/- ADHD population from childhood through adolescence and into adulthood.

In this study, the investigators aim to evaluate sleep disorders in the SLD population (with or without ADHD) in France through online questionnaires. These questionnaires will be offered to 1,000 children (aged ≥4 years) and adults diagnosed with at least one specific learning disorder.

Primary Objective:

The main objective of this study is to assess the frequency and nature of sleep disorders in patients (both adults and children) with specific learning disorders, with or without ADHD.

Secondary Objectives:

  • Characterize the "SLD" patient population in France by considering age and gender:
  • Determine the prevalence of co-morbidities, such as: ADHD Anxiety and depressive disorders Other reported medical conditions
  • Assess the types of care provided (medication or other) for both children and adults
  • Determine the frequency of SLD in a familial context
  • Identify whether the following factors are associated with a higher frequency of sleep disorders:
  • Single SLD vs. multiple SLD
  • The presence of ADHD, anxiety-depressive disorders, or other medical conditions alongside SLD
  • Demographic characteristics (age, gender, etc.)
  • Family history of SLD among relatives (parents and siblings)
  • Medication use
Being tested
Online Questionnaire
Keywords
Specific learning disabilities, Sleep, ADHD, Paediatric
Medical subject headings
Sleep Wake Disorders, Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online QuestionnaireOther

    Completion of an online questionnaire via the secure RedCap platform

Study groups in NCT06878690
Study groupRoleWhat they receive
ChildrenChildren (4 < 18 years old) with specific learning disabilities, associated or not with others medical condition
Receives: Other: Online Questionnaire
AdultAdult (> 18 years old) with specific learning disabilities, associated or not with others medical condition
Receives: Other: Online Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Characterization of sleep disorders assessed using the Sleep Disturbances Scale for Children (SDSC) questionnaires in children

    Scores are obtained after completing the different subsections of the questionnaire. The subsections represent the different sleep disorders. The scores obtained in the different subsections define whether a disorder is present or not.

    Measured: Baseline

  2. Characterization of sleep disorders assessed using the Pittsburg Sleep Quality Index score in adults

    Scores are obtained after completing the different subsections of the questionnaire. The subsections represent the different sleep disorders. The scores obtained in the different subsections define whether a disorder is present or not.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start16 Apr 2025
  3. Primary completion16 Apr 2026
  4. Study completion16 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
1,146 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06878690
Sponsor's protocol ID
69HCL24_0276
Other IDs
2024-A01674-43
Acronym
DYSOM
Status last verified
May 2026
First submitted
5 Mar 2025
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Specific Learning Disability and Sleep, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Characterization of sleep disorders assessed using the Sleep Disturbances Scale for Children (SDSC) questionnaires in children (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in